IL99581A - Substituted-4-amino-3-pyridinols, a process for their preparation and pharmaceutical compositions containing them - Google Patents

Substituted-4-amino-3-pyridinols, a process for their preparation and pharmaceutical compositions containing them

Info

Publication number
IL99581A
IL99581A IL9958191A IL9958191A IL99581A IL 99581 A IL99581 A IL 99581A IL 9958191 A IL9958191 A IL 9958191A IL 9958191 A IL9958191 A IL 9958191A IL 99581 A IL99581 A IL 99581A
Authority
IL
Israel
Prior art keywords
compound
formula
hydrogen
loweralkyl
pyridinol
Prior art date
Application number
IL9958191A
Other languages
English (en)
Other versions
IL99581A0 (en
Original Assignee
Hoechst Roussel Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma filed Critical Hoechst Roussel Pharma
Publication of IL99581A0 publication Critical patent/IL99581A0/xx
Publication of IL99581A publication Critical patent/IL99581A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/26—Radicals substituted by halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Psychiatry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Surface Treatment Of Glass (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL9958191A 1990-09-27 1991-09-26 Substituted-4-amino-3-pyridinols, a process for their preparation and pharmaceutical compositions containing them IL99581A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US58911390A 1990-09-27 1990-09-27

Publications (2)

Publication Number Publication Date
IL99581A0 IL99581A0 (en) 1992-08-18
IL99581A true IL99581A (en) 1995-07-31

Family

ID=24356648

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9958191A IL99581A (en) 1990-09-27 1991-09-26 Substituted-4-amino-3-pyridinols, a process for their preparation and pharmaceutical compositions containing them

Country Status (22)

Country Link
US (3) US5821239A (enExample)
EP (1) EP0477903B1 (enExample)
JP (1) JP3090511B2 (enExample)
KR (1) KR100215357B1 (enExample)
AT (1) ATE136297T1 (enExample)
AU (1) AU637720B2 (enExample)
CA (1) CA2052433C (enExample)
CZ (1) CZ282002B6 (enExample)
DE (1) DE69118470T2 (enExample)
DK (1) DK0477903T3 (enExample)
ES (1) ES2085940T3 (enExample)
FI (1) FI914504A7 (enExample)
GR (1) GR3019742T3 (enExample)
HU (1) HUT60247A (enExample)
IE (1) IE73874B1 (enExample)
IL (1) IL99581A (enExample)
NO (1) NO913778L (enExample)
NZ (1) NZ239935A (enExample)
PT (1) PT99073B (enExample)
TW (1) TW200462B (enExample)
YU (1) YU158591A (enExample)
ZA (1) ZA917692B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6218383B1 (en) 1998-08-07 2001-04-17 Targacept, Inc. Pharmaceutical compositions for the prevention and treatment of central nervous system disorders
FR2813891B1 (fr) * 2000-09-14 2005-01-14 Immunotech Sa Reactif multifonctionnel pour erythrocytes mettant en jeu des carbamates et applications
DE10102791B4 (de) * 2001-01-22 2004-04-15 Ifm Electronic Gmbh Elektrischer Meßumformer
BR0214967A (pt) * 2001-12-14 2005-05-10 Novo Nordisk As Composto, sal famaceuticamente aceitável, processo para a preparação de um composto, composição farmacêutica, uso de um composto e método de tratar um distúrbio de um paciente
KR100443983B1 (ko) 2002-01-15 2004-08-09 삼성전자주식회사 냉장고
US8007826B2 (en) 2003-12-11 2011-08-30 Acorda Therapeutics, Inc. Sustained release aminopyridine composition
US8354437B2 (en) 2004-04-09 2013-01-15 Acorda Therapeutics, Inc. Method of using sustained release aminopyridine compositions
MX2007010076A (es) 2005-02-17 2007-10-16 Astellas Pharma Inc Derivado de heterociclico-1-carboxilato que contiene nitrogeno no aromatico de piridilo.
CN101827522A (zh) * 2008-09-10 2010-09-08 阿索尔达治疗股份有限公司 持续释放氨基吡啶组合物的使用方法
EP2533645B1 (en) 2010-02-09 2016-07-27 The Johns Hopkins University Methods and compositions for improving cognitive function
US10154988B2 (en) 2012-11-14 2018-12-18 The Johns Hopkins University Methods and compositions for treating schizophrenia
US9211288B2 (en) 2012-12-13 2015-12-15 H. Lundbeck A/S Compositions comprising vortioxetine and donepezil
US10806717B2 (en) 2013-03-15 2020-10-20 The Johns Hopkins University Methods and compositions for improving cognitive function
CA2904767C (en) 2013-03-15 2022-06-21 Agenebio, Inc. Methods and compositions for improving cognitive function
EA034167B8 (ru) 2015-05-22 2021-04-27 Эйджинбайо, Инк. Фармацевтические композиции леветирацетама пролонгированного высвобождения
JP6899120B2 (ja) * 2016-10-12 2021-07-07 株式会社ナノエッグ アセチルコリンエステラーゼ(AChE)阻害剤

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179563A (en) * 1978-05-19 1979-12-18 Warner-Lambert Company 3-Aryloxy-substituted-aminopyridines and methods for their production
US4734275A (en) * 1983-08-19 1988-03-29 Research Corporation Anti-curare agents
DE3514073A1 (de) * 1985-04-18 1986-10-23 Hoechst Ag, 6230 Frankfurt Mehrfach substituierte pyridin-1-oxide, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung
US4735958A (en) * 1986-12-22 1988-04-05 Warner-Lambert Company Trans-6-[2-[2-(substituted-phenyl)-3- (or 4-) heteroaryl-5-substituted-1H-pyrrol-1-yl]-ethyl]tetrahydro-4-hydroxy-2H-pyran-2-one inhibitors of cholesterol biosynthesis
US4831044A (en) * 1987-10-29 1989-05-16 Ici Americas Inc. Fungicidal pyridyl cyclopropane carboxamidines
US4994473A (en) * 1987-11-17 1991-02-19 Ici Americas Inc. Pyridyl containing insecticides
EP0361489A3 (en) * 1988-09-30 1991-06-12 Chugai Seiyaku Kabushiki Kaisha Novel 3,4-diaminoquinoline and pyridine compounds
ATE89553T1 (de) * 1988-11-16 1993-06-15 Hoechst Roussel Pharma Hydroxy-1,2,3,4-tetrahydroaminoacridine, verfahren fuer ihre herstellung und ihre verwendung als arzneimittel.
US4931457B1 (en) * 1989-06-28 1993-11-16 Hoechst-Roussel Pharmaceuticals Incorporated Naphthylamino-and naphthyloxy-pyridineamin compounds useful as topical antiinflammatory agents for the treatment of skin disorders

Also Published As

Publication number Publication date
IL99581A0 (en) 1992-08-18
HUT60247A (en) 1992-08-28
NO913778L (no) 1992-03-30
DK0477903T3 (da) 1996-07-29
GR3019742T3 (en) 1996-07-31
US5869480A (en) 1999-02-09
IE913389A1 (en) 1992-04-08
PT99073B (pt) 1999-02-26
HU913075D0 (en) 1992-01-28
ZA917692B (en) 1992-05-27
US5866565A (en) 1999-02-02
PT99073A (pt) 1992-08-31
JPH04261157A (ja) 1992-09-17
EP0477903A2 (en) 1992-04-01
NZ239935A (en) 1995-07-26
US5821239A (en) 1998-10-13
ES2085940T3 (es) 1996-06-16
IE73874B1 (en) 1997-07-02
AU8475691A (en) 1992-04-02
KR100215357B1 (ko) 1999-08-16
FI914504A0 (fi) 1991-09-25
EP0477903A3 (en) 1992-08-05
CZ282002B6 (cs) 1997-04-16
NO913778D0 (no) 1991-09-26
AU637720B2 (en) 1993-06-03
YU158591A (sh) 1994-12-28
ATE136297T1 (de) 1996-04-15
JP3090511B2 (ja) 2000-09-25
FI914504A7 (fi) 1992-03-28
CA2052433C (en) 2003-04-15
KR920006318A (ko) 1992-04-27
EP0477903B1 (en) 1996-04-03
CS293691A3 (en) 1992-04-15
TW200462B (enExample) 1993-02-21
DE69118470T2 (de) 1996-09-19
CA2052433A1 (en) 1992-03-28
DE69118470D1 (de) 1996-05-09

Similar Documents

Publication Publication Date Title
KR100340372B1 (ko) 치환된 3-(아미노알킬아미노)-1,2-벤즈이속사졸, 이의 제조방법 및 이를 포함하는 약제학적 조성물
US5821239A (en) Substituted-4-amino-3-pyridinols
US5708007A (en) 2-(piperidin-4-yl, pyridin-4-yl and tetrahydropyridin-4-yl) benzofuran-7-ol and carbamate derivatives for treating memory dysfunction
EP0535645B1 (en) Carbamate derivatives of 4-amino-3-isoxazolidinones and 3-amino-1-hydroxypyrrolidin-2-ones, a process for their preparation and their use as medicaments
US5519131A (en) Synthesis of pyridooxazinyl-indoles
EP0468401B1 (en) 1-(Substituted pyridinylamino)-1H-indol-5-yl substituted carbamates, a process for their preparation and their use as medicaments
US5100891A (en) Substituted 1,2,3,4-tetrahydrocyclopent[b]indoles, 1,2,3,3a,4,8a-hexahydrocyclopent[B]indoles and related compounds
JP2961013B2 (ja) 〔(アリールアルキルピペリジン−4−イル)メチル〕−2a,3,4,5−テトラヒドロ−1(2H)−アセナフチレン−1−オン類および関連化合物
JP2749259B2 (ja) テトラヒドロシクロペント〔b〕インドールメタンアミン類および関連化合物、それらの製造方法および医薬としてのそれらの使用
US5688816A (en) Carbamoyl-1-(pyridinylalkyl)-1H-indoles, indolines and related analogs
US5091541A (en) Hexahydropyrrolo(2,3-B)indole carbamates, ureas, amides and related compounds
US5173497A (en) Alpha-oxopyrrolo[2,3-B]indole acetic acids, esters, amides and related analogs
US4983616A (en) Hexahydropyrrolo(2,3-B)indole carbamates, ureas, amides and related compounds
US5472975A (en) Substituted 1,2,3,4-tetrahydrocyclopent[b]indoles, 1,2,3,3a,4,8a-hexahydrocyclopent[b]indoles and related compounds
US5264587A (en) Method of preparing α-oxopyrrolo[2,3-b]indole acetic acids and derivatives
US4920117A (en) 4,5,5a,6-tetrahydro-3H-isoxazolo(5,4,3-kl)acridines, pharmaceutical compositions and use
US4942237A (en) Method of preparing isoxazolo(5,4,3-kl)acridines

Legal Events

Date Code Title Description
HC Change of name of proprietor(s)
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees